Fresenius SE & Co. (OTCMKTS:FSNUY) Sees Unusually-High Trading Volume – Still a Buy?

Posted by Teresa Graham on Jan 6th, 2026

Shares of Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) saw an uptick in trading volume on Tuesday . 139,025 shares traded hands during trading, an increase of 189% from the previous session’s volume of 48,048 shares.The stock last traded at $14.1750 and had previously closed at $13.98.

Wall Street Analyst Weigh In

Several research firms have weighed in on FSNUY. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Fresenius SE & Co. in a research note on Monday, October 27th. Morgan Stanley reaffirmed an “overweight” rating on shares of Fresenius SE & Co. in a research report on Monday, December 15th. Two investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Fresenius SE & Co. has an average rating of “Buy”.

Get Our Latest Stock Report on Fresenius SE & Co.

Fresenius SE & Co. Stock Performance

The stock has a market cap of $31.66 billion, a price-to-earnings ratio of 25.76 and a beta of 0.76. The company’s fifty day simple moving average is $14.71 and its two-hundred day simple moving average is $13.79. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.26 and a quick ratio of 0.99.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last issued its quarterly earnings data on Wednesday, November 5th. The company reported $0.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.21 by $0.02. Fresenius SE & Co. had a net margin of 5.26% and a return on equity of 9.72%. The firm had revenue of $6.29 billion during the quarter, compared to analysts’ expectations of $6.38 billion. On average, analysts forecast that Fresenius SE & Co. will post 0.79 earnings per share for the current year.

About Fresenius SE & Co.

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.